Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Releases Preclinical Data on Lipid Delivery of mRNA

Premium

Tekmira Pharmaceuticals this week announced the release of preclinical data showing that its lipid nanoparticles can be used to deliver messenger RNA into the liver, tumors, and other tissues in vivo.

The data were presented at the International mRNA Health conference in Germany this week.

"Because [lipid nanoparticles] can enable a wide variety of nucleic acid payloads, including messenger RNA, we continue to see new product development and partnering opportunities based on our … delivery expertise," Tekmira President and CEO Mark Murray said in a statement.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.